BioNTech Shares Slide After Q2 Revenue, EPS Miss
By Scott Kanowsky Investing.com -- Shares in BioNTech SE (ETR:22UAy) slumped on Monday after the German medicine maker posted less-than-expected second quarter revenues and earnings despite...
Neutral
or
BioNTech SE News & Analysis
-
-
Dollar Stabilizes After Sharp Drop; Jackson Hole Meeting in Focus
By Peter Nurse Investing.com - The dollar stabilized in early European trade Tuesday, following its sharpest one-day fall since May, with traders repositioning ahead of the Federal Reserve’s...
-
UPDATE 2-European stocks end at record highs as miners rally
* UK to announce lockdown easing* Miners jump to 10-year high* UK airlines dip on limited easing of restrictions (Adds comments, updates prices throughout)By Sruthi Shankar and Shreyashi...
-
European stocks hit fresh record high as miners rally
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)May 10 (Reuters) - European stocks extended a record-setting rally on Monday as...
-
EXPLAINER-COVID-19 vaccine patent waiver talks could still take months
By Philip BlenkinsopBRUSSELS, May 6 (Reuters) - President Joe Biden threw his support behind waiving intellectual property rights for COVID-19 vaccines in a sharp U.S. reversal, but it could...
-
EXPLAINER-COVID-19 vaccine patents dominate global trade talks
By Philip Blenkinsop BRUSSELS, May 5 (Reuters) - World Trade Organization members will assess on Wednesday signs of progress in talks on a proposal by South Africa and India to waive patent...
-
UK lawmakers call for PM Johnson to publish big pharma lobbying messages
LONDON, April 26 (Reuters) - British lawmakers on Monday called on the government to publish all communications with pharmaceutical companies to understand if private lobbying influenced its...
-
Dollar struggles to recover after slump to 7-week trough amid lower U.S. yields
* Yen sets fresh seven-week high as stocks decline * Commodity currencies weaker after drop in oil * Risk sentiment sours as pandemic fears return By Kevin Buckland TOKYO, April 21 (Reuters)...
-
FOREX-Dollar licks wounds after drop to 7-week trough amid lower U.S. yields
* Yen sets fresh seven-week high as stocks decline* Commodity currencies weaker after drop in oil* Graphic: World FX rates https://tmsnrt.rs/2RBWI5EBy Kevin BucklandTOKYO, April 21 (Reuters)...
-
FOREX-Dollar rises from lows; oil drop hits crude-linked currencies
(Revises throughout, updates prices, adds action in Canadian dollar, emerging markets)* Dollar rises after dipping to lowest since March 3* Euro gives up some gains from vaccination news*...
-
FOREX-Dollar firms after nearing seven-week lows
(Updates prices)* Dollar firms after dipping to lowest since March 3* Euro strengthens* British pound tests $1.40, then eases* Graphic: World FX rates https://tmsnrt.rs/2RBWI5EBy David...
-
CORRECTED-FOREX-Dollar steadies near seven-week lows as interest rates hold
(Corrects strategist's name in second reference)* Dollar firms after dipping to lowest since March 3* Euro strengthens* British pound tests $1.40, then eases* Graphic: World FX rates...
-
FOREX-Dollar steadies near seven-week lows; euro holds above $1.20
* Dollar index falls to lowest since March 3* Euro, Aussie and Kiwi dollars strengthen* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E (Updates prices, adds comment)By Elizabeth...
-
Dollar falls to lowest in more than seven weeks
* Dollar index falls to lowest since March 3 * Euro, Aussie and Kiwi dollars strengthen LONDON, April 20 (Reuters) - The dollar dropped to its lowest in nearly seven weeks during the Asian...
-
Vaccine hopes boost euro; dollar dips amid subdued U.S. yields
* Euro supported as Europe closes gap with U.S. vaccine drive * Dollar skids after Treasury yields retreat from 14-month peaks * Euro, yen at highest level versus dollar since early March By...
-
FOREX-Vaccine hopes boost euro, dollar on back foot as yields off highs
* Euro propped up by vaccination catch-up hopes* Dollar loses traction as U.S. bond yields subdued* Euro, yen at highest level vs dollar since early March* Graphic: World FX rates...
-
UPDATE 2-South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says
(Updates April 10 story with additional information from researchers)By Maayan LubellJERUSALEM, April 18 (Reuters) - The coronavirus variant discovered in South Africa can break through the...
-
UPDATE 1-Brazil, Mexico, Philippines among those due to get Pfizer shots from COVAX in Q2 - statement
(Adds details)GENEVA, April 12 (Reuters) - Some 14.1 million doses of the Pfizer (NYSE:PFE) PFE.N BioNTech 22UAy.DE COVID-19 vaccine have been allocated to 47 countries and economies for...
-
Brazil, Mexico, Philippines among those due to get Pfizer shots from COVAX in Q2 - statement
GENEVA, April 12 (Reuters) - Some 14.1 million doses of the Pfizer (NYSE:PFE) PFE.N BioNTech 22UAy.DE COVID-19 vaccine have been allocated to 47 countries and economies for delivery in the...
-
UPDATE 1-South African variant may evade protection from Pfizer vaccine, Israeli study says
(Updates April 10 story with details on plans for a booster shot)By Maayan LubellJERUSALEM, April 10 (Reuters) - The coronavirus variant discovered in South Africa may evade the protection...
-
South African variant can 'break through' Pfizer vaccine, Israeli study says
By Maayan LubellJERUSALEM, April 10 (Reuters) - The coronavirus variant discovered in South Africa can "break through" Pfizer/BioNTech's COVID-19 vaccine to some extent, a real-world data...
-
South African business confidence inches lower in March
JOHANNESBURG, April 7 (Reuters) - South African business confidence inched lower in March, data showed on Wednesday, constrained by uncertainty over the country's economic recovery and fears...
-
UPDATE 1-South Africa's rand and stocks firmer in risk-on trade
(Adds latest prices, analyst comments)JOHANNESBURG, April 6 (Reuters) - South Africa's rand edged firmer to a new five-week best on Tuesday, boosted by greater risk demand as U.S. treasuries...
-
UPDATE 1-South Africa signs deal for 20 million Pfizer vaccine doses
(Add detail on pricing, context)JOHANNESBURG, April 6 (Reuters) - South Africa has signed an agreement to buy 20 million doses of the Pfizer-BioNTech PFE.N 22UAy.DE dual-shot COVID-19...
-
UPDATE 1-South Africa approves Pfizer-BioNTech COVID vaccine for emergency use
(Adds detail, context) JOHANNESBURG, March 16 (Reuters) - South Africa's drugs regulator SAHPRA said on Tuesday that it had approved a "section 21" emergency use application for the COVID-19...
-
South African regulator approves Pfizer/BioNTech vaccine for emergency use
JOHANNESBURG, March 16 (Reuters) - South Africa's drugs regulator SAHPRA said on Tuesday that it had approved a "section 21" emergency use application for the COVID-19 vaccine developed by...
-
UPDATE 2-South Africa advisers back Pfizer COVID-19 vaccine after study
* South Africa expecting 7 mln Pfizer (NYSE:PFE) doses by June* Study suggested variant may reduce protective antibodies* Advisers say vaccine still good fit for country* S.Africa...
-
South African vaccine adviser backs Pfizer shot after study
JOHANNESBURG, Feb 19 (Reuters) - One of the South African government's top advisers on COVID-19 vaccines said on Friday that the Pfizer-BioNTech PFE (NYSE:PFE).N 22UAy.DE shot was "still a...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
